GlassScriptPhysician profile
Amanda Bucca
NPI 1831597343
$601.52
in general payments reported to CMS, 2019-2025
16 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.06 · 2022: $83.93 · 2023: $105 · 2024: $151 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $162.63 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $76.78 | 2022-2024 | |
| Collegium Pharmaceutical, INC. | $52.19 | 2025 | Jornay Pm |
| Cranial Technologies, INC | $44.33 | 2023-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $39.94 | 2025 | |
| Cipher Pharmaceuticals US LLC | $37.64 | 2025 | Spinosad, Natroba |
| Merck Sharp & Dohme LLC | $29.21 | 2023-2024 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $28.73 | 2022-2024 | Qelbree |
| Sanofi Pasteur INC. | $19.58 | 2024 | |
| Pfizer INC. | $18.77 | 2025 | |
| Lnhc, INC | $16.49 | 2025 | Zelsuvmi |
| Avion Pharmaceuticals | $16.19 | 2023 | Methylphenidate Hydrochloride |
| Tris Pharma INC | $15.49 | 2022 | |
| Exeltis, USA INC. | $14.61 | 2025 | Slynd |
| Azurity Pharmaceuticals, INC. | $14.59 | 2025 | Alvesco |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $14.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Bucca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.